Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy (Q34315086)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

main subject

ovarian cancer

1 reference

based on heuristic

inferred from title

author name string

Gibbs DD

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

Gore ME

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

publication date

1 January 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

volume

61

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

page(s)

1103-1120

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

cites work

Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in patients with stage I epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced stage III ovarian carcinoma. Prospective randomized trials comparing radiotherapy and chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreduction for ovarian cancer following cisplatin therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of high-dose versus low-dose cis-platinum combined with cyclophosphamide in the treatment of advanced ovarian cancer. Hong Kong Ovarian Carcinoma Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel vs epidoxorubicin plus paclitaxel as second-line therapy for platinum-refractory and -resistant ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of adjuvant therapy in Stage I ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of Life of Women with Ovarian Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predictive of survival after first relapse or progression in advanced epithelial ovarian carcinoma: a prediction tree analysis-derived model with test and validation groups.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage IV ovarian cancer: impact of surgical debulking

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of surgical debulking on survival in stage IV ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the ovary, stages I and II. A prospective randomized study of the effects of postoperative chemotherapy and radiotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BAX protein expression and clinical outcome in epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of early ovarian cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of doxorubicin on survival in advanced ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative surgery for Stage I ovarian carcinoma in women of childbearing age

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of stage IV epithelial ovarian cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical treatment of recurrent ovarian cancer: report of 21 cases and a review of the literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: A multivariate analysis of 704 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical staging of carcinoma of the ovaries

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical model to determine the relationship of response and survival in patients with advanced ovarian cancer treated with chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with independent radiological review during a topotecan trial in ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11465872

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-200161080-00006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

Dimensions Publication ID

1022644374

0 references

PubMed publication ID

11465872

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11465872

retrieved

1 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34315086&oldid=2196495455"